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ABSTRACT 
The current study aimed to examine the renoprotective effects of long-term treatment with sodium hydrosulfide 
(NaHS), a prominent hydrogen sulfide donor, in 5/6 nephrectomy animal model. Twenty-four rats were randomly 
divided into 3 groups including sham-operated group (Sham), 5/6-nephrectomized group (5/6 Nx), and NaHS-
treated group (5/6Nx+NaHS). NaHS (30 micromol/l) was added twice daily into the drinking water and renal 
failure was induced by 5/6 nephrectomy. Twelve weeks after surgical procedure, blood pressure, creatinine clear-
ance (CCr), urine concentration of neutrophil gelatinase associated lipocalin (NGAL) and tissue concentration of 
malondialdehyde (MDA), superoxide dismutase (SOD), as well as renal morphological changes, apoptosis 
(cleaved caspase-3) and inflammation (p-NF-κB) were measured. Five-sixth nephrectomy induced severe renal 
damage as indicated by renal dysfunction, hypertension and significant histopathological injury which were asso-
ciated with increased NGAL and MDA levels, oxidant/antioxidant imbalance, decreased SOD activity and CCr 
and also overexpression of p-NF-κB and cleaved caspase-3 proteins. Instead, NaHS treatment attenuated renal 
dysfunction through reduction of NGAL concentration, hypertension, CCr, oxidant/antioxidant imbalance, inflam-
mation and apoptosis. These findings suggest that long term NaHS treatment can be useful in preventing the pro-
gression of CKD by improving oxidant/antioxidant balance and reducing inflammation and apoptosis in the kid-
ney.  
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INTRODUCTION 
Chronic kidney disease (CKD) is a global 
public health problem (Askari et al., 2016). 
CKD is defined as decreased estimated glo-
merular filtration rate (eGFR) lower than 60 
mL/min per 1·73 m2, or the presence of mark-
ers of renal damage in urine such as urinary 
neutrophil gelatinase-associated lipocalin 
(uNGAL) (Marcuccilli and Chonchol, 2016; 
Targher et al., 2014). After initial injury to the 
kidneys due to systemic hypertension, inflam-
mation and oxidative stress, a compensatory 
and adaptive response in the nephrons begins 
which ultimately induces detrimental effects 
to the renal tissue and causes further nephron 
loss and end-stage kidney disease. In this con-
text, structural modifications in CKD patients 
may cause oxidative stress related to an im-
balance between free radical's production and 
antioxidant capacity. This, in turn directly 
triggers systemic inflammation by activation 
of redox-sensitive proinflammatory transcrip-
tion factors and signal transduction pathways 
which cause apoptosis and further progres-
sion of renal injury (Akchurin and Kaskel, 
2015; Vaziri, 2008). Currently, the therapeu-
tic options available for managing CKD are 
not quite efficient and therefore, there lies a 
subsequent need for effective drug therapies 
that can prevent progressive damage to the 
kidneys. Recent evidence suggests that hydro-
gen sulfide (H2S), a novel gaseous signaling 
molecule similar to nitric oxide (NO) and car-
bon monoxide (CO), can exhibit renoprotec-
tive effects in the animal model of kidney in-
jury (Shui et al., 2016; Wesseling et al., 2015) 
via antihypertensive, antioxidative, antiapop-
totic and anti-inflammatory mechanisms (Ju 
et al., 2013; Snijder et al., 2014; Wu et al., 
2017b). Therefore, given the critical role of 
oxidative stress, hypertension, inflammation 
and apoptosis in the progression of renal dis-
ease and the potent protective actions of H2S 
in kidney disease, the present study was de-
signed to investigate the effect of pharmaco-
logical long-term sodium hydrosulfide 
(NaHS) treatment on 5/6 nephrectomy animal 
model.  
 
METHODS 
Experimental design 
The experiment procedures were ap-
proved by Tehran University of Medical Sci-
ences ethical committee and were in accord-
ance with the National Institutes of Health 
Publication, Animal Care and Use of Labora-
tory Animals guidelines. Male Wistar rats, 
weighing 200–250 g, were housed under 
standard conditions (12 h light–dark cycle; 
20–22 °C) with free access to water and a 
standard rat diet and randomly assigned to 
control (n=8) and CKD (n=16) subjects. CKD 
was induced by a two-step 5/6 nephrectomy 
(5/6 Nx) as described previously (Askari et 
al., 2016). All these CKD rats were housed for 
four weeks to establish the 5/6 nephrectomy 
model and then equally randomized to receive 
NaHS (30 micromol/l twice daily) in drinking 
water or drinking water alone daily for 8 
weeks. Sham surgery was performed in the 
same way as described for CKD with the ex-
ception of no manipulation of the kidneys. 12 
weeks' post-surgery the values of systolic 
blood pressure were measured between 13:00 
and 16:00 hours by the tail-cuff method con-
nected to a pulse transducer device 
(MLT125/R; AD Instruments, Castle Hill, 
NSW, Australia). The transducer was con-
nected to a PowerLab/4SP data-acquisition 
system (Chart, version 5; AD Instruments). 
Five measurements were taken for each rat 
and subsequently averaged. After 12 weeks, 
the animals were weighed and placed in met-
abolic cages for a 24 h urine collection and 
then anaesthetized to obtain their blood sam-
ples from the inferior vena cava. Finally, kid-
neys tissue was taken for oxidative stress sta-
tus. Part of the kidney was fixed in 10 % for-
malin for histological assessment and im-
munohistochemistry. 
 
Biochemical assay 
Urine samples were collected at the end of 
the experiments and the total volumes were 
recorded. In conjunction with serum creati-
nine concentration and urine volume, urinary 
creatinine concentration was measured by 
colorimetric methods to calculate creatinine 
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clearance (CCr) using standard formulas. 
Moreover, urine NGAL levels were measured 
by lipocalin-2 (NGAL) Rat ELISA Kit 
(ab119602) according to manufacturer’s pro-
tocol.  
 
Evaluation of renal markers of oxidative 
stress  
Lipid peroxidation (MDA) assay 
Malondialdehyde (MDA) levels were 
measured in tissue samples using the thiobar-
bituric acid reactive substances (TBARS) 
method according to the methods of Es-
terbauer and Cheeseman (Elshiekh et al., 
2017; Esterbauer and Cheeseman, 1990). The 
values were expressed as µmol/100 mg tissue. 
Superoxide dismutase activity assay 
Renal tissue SOD activity was assessed 
according to the spectrophotometric method 
of Paoletti and Mocali (1988). Oxidation of 
NADPH is linked to the availability of super-
oxide anions in the medium. The values were 
expressed as U/g tissue. 
Immunohistochemistry evaluation 
Kidney samples of the different groups 
were fixed in formalin and embedded in par-
affin and sections of 3 μm were cut with a mi-
crotome and stained with hematoxylin and eo-
sin according to standard procedures. At least 
8 random non-overlapping areas at 100 mag-
nifications were observed for the presence of 
tubular necrosis, tubular dilatations and loss 
of brush borders, as well as the formation of 
casts and luminal debris. Sections were 
graded as follows: 0: minimal or no lesions; 
1: < 25 % of tubules were involved; 2: 25 %–
50 % of tubules were involved; 3: > 50 % of 
tubules were involved (Jablonski et al., 1983). 
For fluorescent immunocytochemistry, 
briefly, the paraffin sections were deparaf-
finized by xylene and then hydrated by im-
mersion into decreasing concentrations of 
ethanol. At least 30 sections provided and col-
lected onto poly-L-lysine coated cover slips 
for each independent experiment. After that, 
for antigen retrieval, slides were pretreated by 
trypsin solution which can significantly re-
open the cross-linked epitopes so that anti-
bodies can quickly stick to target antigens. 
Non-specific protein binding was blocked by 
2 h incubation in 1 % BSA+FBS 10 % in 
TBS-Tween. Next, the sections were incu-
bated (4 °C) overnight with two primary anti-
bodies including mouse monoclonal antibody 
against p-NF-κB as inflammatory marker (sc-
136548, 1:400; Santa Cruz Biotechnology) 
and rabbit monoclonal antibody against 
cleaved caspase-3 as apoptosis marker 
(9579S, 1:300; Cell Signaling Technology). 
Thereafter, sections were 6-h (room tempera-
ture) incubated with the secondary antibodies 
(Santa Cruz Biotechnology) including fluo-
rescein isothiocyanate (FITC) conjugated 
goat anti-mouse IgG (1:500) to detect p-NF-
κB, texas red (TR) conjugated goat anti-rabbit 
IgG (1:500) to detect cleaved caspase-3. All 
sections were counterstained with 4',6-dia-
midino-2-phenylindole (DAPI) to visualize 
the nuclei. Using a fluorescence microscopy 
images were captured and quantified using 
the NIH ImageJ analysis program (NIH, Be-
thesda, MD, USA) (Sanadgol et al., 2017). p-
NF-κB and cleaved caspase-3 positive immu-
noreactivity were measured after background 
subtraction. Similar threshold level was set 
for every image, on the dark background and 
the positive signals were quantified. 
 
Statistical analysis 
Data are expressed as mean ± SEM. Sta-
tistical analysis between groups were com-
pared by one-way ANOVA and followed by 
post hoc Tukey’s test. The level of signifi-
cance was set at p<0.05. 
 
RESULTS 
Long-term NaHS treatment attenuates the 
progression of renal dysfunction in 5/6 Nx 
rats 
Figure 1 and Table 1 present the results of 
treatment with NaHS for 8 weeks on renal 
function and general characteristics. As 
shown, creatinine clearance was significantly 
decreased after 12 weeks in the 5/6 Nx rats as 
compared with the sham rats (p<0.001). 
Moreover, other clinical indices such as body 
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weight (p=0.003), blood pressure (p<0.001) 
and CKD progression, evidenced by NGAL 
biomarker (p=0.015), were significantly dif-
ferent in sham and 5/6 Nx rats 12 weeks' post-
surgery. We noted a significant increase in 
creatinine clearance (p<0.001) and body 
weight (p=0.024) after treatment with NaHS. 
In addition, urine concentration of NGAL 
(p<0.05) as well as systolic blood pressure 
p=047) were markedly reduced in 5/6 Nx+ 
NaHS group as compared to 5/6 Nx subjects. 
 
Long-term NaHS treatment attenuates  
renal oxidative stress in 5/6 Nx rats 
Five-sixth nephrectomy resulted in signif-
icant increase in MDA contents as compared 
with the sham group (p<0.01). In contrast, 
NaHS significantly reduced MDA content in 
5/6 Nx+ NaHS subjects (p<0.05) as compared 
with the 5/6 Nx group (Figure 2a). Compared 
with the sham group, 5/6 nephrectomy re-
sulted in significant decrease in SOD activity 
(p=0.009). The activity of SOD was markedly 
elevated in the NaHS group (p=0.014) as 
compared with the 5/6 Nx group (Figure 2b). 
 
Long-term NaHS treatment significantly  
attenuated histological damage in 5/6 Nx 
rats 
The histological evaluations showed no 
obvious signs of damage to the glomeruli or 
tubules in the kidneys of sham group (Figure 
3). In the 5/6 Nx group, the most noticeable 
change was the widening Bowman’s space in 
the glomeruli of the kidneys. There were also 
extensive tubular dilations present in proxi-
mal and distal tubules. Tubular debris was 
present and leukocytes infiltrations were also 
frequent in these tissues. In the 5/6 Nx +NaHS 
kidneys, the degree of Bowman’s space wid-
ening was lower and less tubular casts were 
present as compared to 5/6 Nx group.  
 
 
Figure 1: Effect of NaHS on (a) creatinine clearance and (b) urine lipocalin-2 (NGAL) concentration in 
5/6 Nx rats. The data are presented as mean ± SEM (n=8). *p<0.05 vs sham group and #p<0.05 vs 5/6 
Nx group 
 
 
Table 1: Effect of NaHS on systolic blood pressure and body weight in 5/6 Nx rats. The data are pre-
sented as mean ± SEM (n=8). *p < 0.05 vs sham group.  #p < 0.05 vs 5/6 Nx group  
General characteristics of rats 12 weeks after surgery 
Parameter Sham 5/6 Nx rats 5/6 Nx rats+ 
NaHS 
Systolic blood pressure  
(mm Hg) 
98.77 ± 5.20 143.63 ± 8.50 * 123.75 ± 6.95 # 
Body weight (g) 309.75 ± 2.25 281.5 ± 4.76 * 317.25 ± 7.75   # 
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Figure 2: Effect of NaHS on (a) malondialdehyde (MDA) content and (b) superoxide dismutase (SOD) 
activity in 5/6 Nx rats. The data are presented as mean ± SEM (n=8).*p<0.05 vs sham group and #p<0.05 
vs 5/6 Nx group 
Figure 3: Renal histological changes in the (a) sham, (b) 5/6 nephrectomy (5/6 Nx) and (c) 5/6 Nx+ 
NaHS groups. The histological changes observed 12 weeks after surgery (a) there was no obvious 
damage to the glomeruli or tubules in the kidneys of sham group. (b) In the 5/6 Nx group, the most 
noticeable change was the Bowman’s space widening which was present in the glomeruli of the kidneys. 
There were also extensive tubular dilations which were present in all proximal and distal tubules. Tubular 
debris was present and leukocytes infiltrations were also frequent in these tissues. (c) In the Nx + NaHS 
kidneys the degree of Bowman’s space widening was lower and also less tubular casts was present 
comparing to 5/6 Nx group. Magnification ×400; Hematoxylin and Eosin staining. Scale bar is 200 µm. 
The black thin arrow indicates cast formation, the white arrow shows widening of the Bowman's space. 
The black thick arrow indicates tubular obstruction. (d) Summary of the histological damage. Histological 
damage was scored as follows: 0: minimal or no lesions; 1: < 25 % of tubules involved; 2: 25 %–50 % 
of tubules involved; 3: > 50 % of tubules involved. Data are presented as the mean and range (n=8). 
*p<0.05 vs sham group and #p<0.05 vs 5/6 Nx group 
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Long-term NaHS treatment significantly  
attenuated cleaved caspase-3 and p-NF-κB 
expression in 5/6 Nx rats 
We investigated if the protective effects of 
NaHS were mediated due to suppression of 
inflammation (p-NF-κB) and apoptosis 
(cleaved caspase-3). As shown in Figure 4, 
five-sixth nephrectomy resulted in overex-
pression of cleaved caspase-3 (p=0.021) and 
p-NF-κB (p<0.001), whereas treatment with 
NaHS resulted in milder expression of 
cleaved caspase-3 (p=0.045) and p-NF-κB 
(p=0.036) in comparison with 5/6 Nx sub-
jects. 
 
 
 
Figure 4: Double stained fluorescence microscopy image of p-NF-κB and cleaved caspase-3 related 
antigen from paraffin-embedded kidney rat 12 week after sham operation or 5/6 nephrectomy. Five-sixth 
nephrectomy resulted in overexpression of cleaved caspase-3 and p-NF-κB, whereas treatment with 
NaHS resulted in milder expression of cleaved caspase-3 and p-NF-κB in comparison with 5/6 Nx sub-
jects. Left side of this figure shows the fluorescence signals obtained with antibodies against p-NF-κB 
(green) or cleaved caspase-3 (red) and DAPI staining of the DNA (blue). Scale bar is 25 µm. (A-C) 
nuclei were stained with DAPI (blue). (D) p-NF-κB was stained with secondary antibodies, no p-NF-κB 
was found in the kidney of rat after sham operation (n = 5–6). (E) p-NF-κB -positive cells (in green) were 
found to be positive in 5/6 Nx. (F) p-NF-κB -positive cells (in green) were found to be positive in 5/6 Nx+ 
NaHS rats. (G) No cleaved caspase-3-positive cells were found in the kidney of rat after sham operation 
(n = 5–6). (H) Cleaved caspase-3-positive cells were found to be positive in 5/6 Nx rats. (I) Cleaved 
caspase-3-positive cells (in red) were found to be positive in 5/6 Nx+ NaHS rats. (J-L) Double stained 
fluorescence microcopy image of p-NF-κB and cleaved caspase-3 was obtained. The right side of this 
figure shows the effects of H2S on cleaved caspase-3 and NF-κB expression in kidney tissue 12 weeks 
after surgery. The data are presented as mean ± SEM (n=8). *p<0.05 vs sham group and #p<0.05 vs 
5/6 Nx group 
 
 
EXCLI Journal 2018;17:14-23 – ISSN 1611-2156 
Received: August 09, 2017, accepted: December 16, 2017, published: January 02, 2018 
 
 
20 
DISCUSSION 
In the present study, we aimed to evaluate 
the effectiveness of NaHS as a potential can-
didate for preventing CKD progression. The 
key findings of our study are: 1) NaHS (donor 
of H2S) reduced blood pressure and increased 
creatinine clearance in 5/6 nephrectomized 
rats, which was accompanied by the reduction 
of NGAL levels, 2) in 5/6 nephrectomized 
rats, NaHS treatment reduced MDA levels 
and increased SOD activity. These results 
were supported by 3) the histological im-
provements and reduced kidney injury in 5/6 
Nx treated rats, and 4) there was a marked de-
crease in cleaved caspase-3 and p-NF-κB ex-
pression after eight weeks of NaHS treatment. 
 The presence of hypertension in 5/6 Nx 
subjects suggests the development of cardio-
vascular dysfunction after CKD which may 
increase the morbidity and mortality in these 
subjects (Askari et al., 2016). To further in-
vestigate cardiovascular dysfunction, we sep-
arated the hearts of rats at the end of 12 weeks 
and calculated the ratio of heart/body weight.  
We found an increased heart/body weight ra-
tio in 5/6 Nx rats in comparison with sham 
and 5/6 Nx + NaHS groups (data is not 
shown), suggesting that CKD may have led to 
cardiac hypertrophy and dysfunction. How-
ever, for this notion, functional changes using 
echocardiography or other appropriate tech-
niques shall be evaluated in future studies. 
Progressive increase in the production of 
reactive species of oxygen (ROS) and 
subsquent decrease in antioxidants after CKD 
appears to be the key features for the patho-
physiology of CKD (Abboud and Henrich, 
2010; Boon et al., 2015). Hence, a significant 
increase in oxidative stress may stimulate cell 
hypertrophy and proliferation and inflamma-
tory-cell infiltration (Abboud  and Henrich, 
2010; Ding et al., 2015) which can lead to in-
creased activity of NF-κB and inflammatory 
responses. Such inflammatory processes, es-
pecially in the presence of ROS may induce 
cytotoxic effects and cause apoptotic cell 
death (Esch et al., 2002). In recent years, it has 
been reported that antioxidants protect the 
kidney against 5/6 nephrectomy by reducing 
renal injury in CKD animals through inhibi-
tion of proinflammatory factors like NF-κB 
(Abboud  and Henrich, 2010; Ding et al., 
2015). Herein, our results showed that tissue 
concentrations of MDA were significantly 
higher in 5/6 Nx rats as compared to sham 
subjects. Furthermore, SOD activity consid-
erably decreased in these subjects. It seems 
that the overexpression of p-NF-κB and 
cleaved caspase-3 in CKD animals is in ac-
cordance with our observations about hyper-
trophy and apoptosis in the end stage kidneys 
which would have contributed to increased 
serum levels of NGAL and decreased clear-
ance of creatinine (Brisco and Testani, 2014; 
Khan and Pandey, 2014). Since the use of 
blood urea nitrogen and serum creatinine due 
to their low predictive values have some 
shortcomings as the main biomarkers of 
CKD, new candidate biomarkers such as neu-
trophil gelatinase-associated lipocalin 
(NGAL) have been introduced for early diag-
nosis of CKD due to its ability to detect tissue 
damage rather than kidney dysfunction 
(Fassett et al., 2011; Yim, 2015). NGAL is a 
secreted glycoprotein and a member of 
lipocalin family that is characterized as an ad-
ipose-derived cytokine involved in the in-
flammatory and immune responses regulated 
by NF-κB (Iannetti et al., 2008). It has been 
shown that exogenous NGAL protects the re-
nal tubular epithelial cells against ische-
mia/reperfusion injury by reducing apoptosis 
(Gong et al., 2012) and converting embryonic 
mesenchymal cells into epithelial cells to 
form tubules and then the complete nephrons 
(Khan and Pandey, 2014). However, most of 
the studies have shown that increased levels 
of NGAL can predict a degree of kidney dys-
function, i.e. higher expression of NGAL is 
parallel with kidney injury and alterations in 
kidney NGAL levels leads to increased uN-
GAL concentrations (He et al., 2015; Peters et 
al., 2011; Yim, 2015). In support of this no-
tion, we reported increased uNGAL concen-
trations in 5/6 Nx rats which may in turn reg-
ulate inflammatory states to cause further im-
pairment of kidneys after CKD induction. 
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In the kidney, the diuretic, natriuretic and 
kaliuretic effects of H2S increase in GFR and 
inhibit tubular sodium re-absorption 
(Aminzadeh and Vaziri, 2012). It has been 
shown that CKD is associated with significant 
reduction in plasma H2S concentration 
(Aminzadeh and Vaziri, 2012). Since CKD is 
accompanied by hypoxic conditions, H2S may 
act as an oxygen sensor to restore oxygen 
balance and cause increased medullary blood 
flow and GFR (Beltowski, 2010). The present 
study established a clear link between NaHS 
treatment in 5/6 Nx rats and increased clear-
ance of creatinine, suggesting that NaHS may 
have improved creatinine clearance by en-
hancing blood flow to the kidneys. Moreover, 
our observation about the reduction in uN-
GAL after NaHS treatment suggests the abil-
ity of H2S to alleviate kidney damage in CKD. 
Similarly, recent work of Sen et al. (2009) in-
dicated that H2S decreases renal damage in a 
rat model of hyperhomocysteinemia-associ-
ated chronic renal failure. We also assessed 
the impact of H2S on histological parameters 
after 5/6 nephrectomy. Histological analysis 
revealed a substantial decrease in glomerular 
hypertrophy and Bowman’s space widening 
as well as a decrease in leukocytes infiltration 
within nephrectomized kidneys. Additionally, 
we showed that H2S potently reduces renal 
apoptosis detected by decreased activity of 
cleaved caspase-3. Inhibition of cleaved 
caspase-3 activity is one possible mechanism 
by which H2S attenuates the extent of apopto-
sis and thereby confines the extent of CKD 
progression (Ford et al. 2013). Due to the an-
tioxidant functions of H2S, it has been pro-
posed that in in vivo and in vitro models, the 
long-term treatment with H2S significantly 
protects the kidney from renal injury by lim-
iting the extent of oxidative damages (Lin et 
al., 2016). In the present study, we examined 
the effects of NaHS for 8 weeks on 5/6 Nx rats 
and found that H2S treatment attenuated 
MDA levels and NF-κB activity, and in-
creased SOD activity at week 12 after induc-
tion of 5/6 nephrectomy, suggesting its long-
term renoprotective effects against CKD. 
Therefore, antioxidant and anti-inflammatory 
actions of H2S may play critical roles in pre-
vention of 5/6 Nx-induced renal oxidative 
damage. Furthermore, regarding our observa-
tion about uNGAL reduction after NaHS ad-
ministration, it is also plausible that H2S has 
an inhibitory effect on p-NF-κB. Previous ev-
idences have indicated that NF-κB mediates 
inflammatory processes (Baeuerle and Balti-
more ,1996; Chen et al., 2009). In non-un-
stimulated states, NF-κB dimers are main-
tained in the cytosol in collaboration with the 
inhibitor of nuclear factor-κB (IκB). Robust 
elevation of pro-inflammatory cytokines such 
as tumor necrosis factor-α (TNF-α), as a con-
sequence of hypoxic cell death of glomeruli 
after CKD induces an inflammatory response 
which is responsible for IκB release from NF-
κB. Activation and localization of p-NF-κB in 
the nucleus regulates the expression of proin-
flammatory cytokines and inflammatory me-
diators, such as NGAL (Avci Cicek et al., 
2016; Lian et al., 2010). Our results also sug-
gest that NGAL levels are related to p-NF-κB 
changes. Considering the potent anti-oxidant 
and anti-inflammatory properties of H2S 
(Aminzadeh and Vaziri, 2012), it seems that 
NaHS may, in part, contribute to confine 
CKD progression by NF-κB and cleaved 
caspase-3 down-regulation after 5/6 nephrec-
tomy.  
Recently, Wu et al. (2017a) investigated 
the effect of hydrogen sulfide using a rat 
model of adenine-induced CRF. Various 
methods, are available for inducing the model 
of chronic kidney disease and none of them 
can ever duplicate the original condition in a 
human kidney. Among these ways to induce 
experimental renal failure is via the admin-
istration of nephrotoxic chemical agents in-
cluding adenine and uranyl nitrate administra-
tion. The disadvantage is obvious biologic or 
pathologic effects of these chemical agents on 
the lymphoid and other organ systems would 
be difficult to control and monitor (Chow et 
al., 2003; Zhang and Kompa, 2014). In our 
study using 5/6 nephrectomy model has re-
mained the developed prototype which 
closely mimics human CKD and is a useful 
model for studying drug responses in CKD. In 
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contrast to what was observed in 5/6 nephrec-
tomy, adenine diet failed to induce kidney 
failure in rabbits as is evident in functional in-
dices in a recent study (Florens et al., 2017). 
In the current study, we investigated the ef-
fects of H2S on CKD induced by 5/6 Nx in 
different dose, administration method and 
longer time in rats. Moreover, we evaluated 
NGAL level which is suggestive of renal in-
jury (Bolignano et al., 2009). 
 
CONCLUSIONS 
Taken together, these findings indicate 
that long-term treatment by NaHS inhibits 
ROS injury and renal damages through inhi-
bition of apoptosis and inflammation. There-
fore, NaHS can be considered as complemen-
tary therapeutic agent in the protection against 
kidney damage in chronic kidney disease. 
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